Literature DB >> 21968712

TGF-β1 re-programs TLR4 signaling in L. donovani infection: enhancement of SHP-1 and ubiquitin-editing enzyme A20.

Sushmita Das1, Krishna Pandey, Ashish Kumar, Abul H Sardar, Bidyut Purkait, Manish Kumar, Sudeep Kumar, Vidya N Ravidas, Syamal Roy, Dharmendra Singh, Pradeep Das.   

Abstract

Visceral leishmaniasis (VL), caused by Leishmania donovani, is a major health concern in India. It represents T-helper type 2 (Th2) bias of cytokines in active state and Th1 bias at cure. However, the role of the parasite in regulating Toll-like receptor (TLR)-mediated macrophage activation in VL patients remains elusive. In this report, we demonstrated that later stages of L. donovani infection rendered tolerance to macrophages, leading to incapability for the production of inflammatory cytokines like tumor necrosis factor (TNF)-α and interleukin (IL)-1β in response to TLR stimulation. Overexpression of transforming growth factor (TGF)-β(1), but not IL-10, resulted in suppressed lipopolysaccharide (LPS)-induced production of TNF-α and downregulation of TLR4 expression in L. donovani-infected macrophages. Recombinant human (rh)TGF-β(1) markedly enhanced tyrosine phosphatase (Src homology region 2 domain-containing phosphatase-1) activity, but inhibited IL-1 receptor-activated kinase (IRAK)-1 activation. Addition of neutralizing TGF-β(1) antibody reversed these effects, and thus suggesting the pivotal role of TGF-β(1) in promoting refractoriness for LPS in macrophages. Surprisingly, the use of a tyrosine phosphatase inhibitor (sodium orthovanadate, Na(3)VO(4)) promoted IRAK-1 activation, confirming the negative inhibitory role of tyrosine phosphatase in macrophage activation. Furthermore, rhTGF-β(1) induced tolerance in infected macrophages by reducing inhibitory protein (IκBα) degradation in a time-dependent manner. In addition, short interfering RNA studies proved that overexpression of A20 ubiquitin-editing protein complex induced inhibitory activity of TGF-β(1) on LPS-mediated nuclear factor-κB activation. Thus, these findings suggest that TGF-β(1) promotes overexpression of A20 through tyrosine phosphatase activity that ensures transient activation of inflammatory signaling pathways in macrophages in active L. donovani infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21968712     DOI: 10.1038/icb.2011.80

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  19 in total

1.  Mechanisms of immune evasion in leishmaniasis.

Authors:  Gaurav Gupta; Steve Oghumu; Abhay R Satoskar
Journal:  Adv Appl Microbiol       Date:  2013       Impact factor: 5.086

2.  TLR9 and MyD88 are crucial for the maturation and activation of dendritic cells by paromomycin-miltefosine combination therapy in visceral leishmaniasis.

Authors:  Sushmita Das; Mukta Rani; Vidyanand Rabidas; Krishna Pandey; Ganesh Chandra Sahoo; Pradeep Das
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 3.  TLRs, future potential therapeutic targets for RA.

Authors:  Hatem A Elshabrawy; Abdul E Essani; Zoltán Szekanecz; David A Fox; Shiva Shahrara
Journal:  Autoimmun Rev       Date:  2016-12-15       Impact factor: 9.754

4.  A Defective Oxidative Burst and Impaired Antigen Presentation are Hallmarks of Human Visceral Leishmaniasis.

Authors:  Susmita Roy; Debanjan Mukhopadhyay; Shibabrata Mukherjee; Susmita Ghosh; Shishir Kumar; Kumkum Sarkar; Dipankar Pal; Pratik Bhowmik; Kausik Mandal; Dolanchampa Modak; Subhasish Kamal Guha; Netai Pramanik; Rama Prosad Goswami; Bibhuti Saha; Mitali Chatterjee
Journal:  J Clin Immunol       Date:  2014-11-25       Impact factor: 8.317

Review 5.  Cytokines and Signaling Networks Regulating Disease Outcomes in Leishmaniasis.

Authors:  Amrita Saha; Souravi Roy; Anindita Ukil
Journal:  Infect Immun       Date:  2022-07-11       Impact factor: 3.609

6.  Enhanced expression of Toll-like receptors 2 and 4, but not 9, in spleen tissue from patients with visceral leishmaniasis.

Authors:  R Kumar; O P Singh; S Gautam; S Nylen; S Sundar
Journal:  Parasite Immunol       Date:  2014-12       Impact factor: 2.280

Review 7.  Deception and manipulation: the arms of leishmania, a successful parasite.

Authors:  Pedro Cecílio; Begoña Pérez-Cabezas; Nuno Santarém; Joana Maciel; Vasco Rodrigues; Anabela Cordeiro da Silva
Journal:  Front Immunol       Date:  2014-10-20       Impact factor: 7.561

8.  The involvement of TLR2 and TLR4 in cytokine and nitric oxide production in visceral leishmaniasis patients before and after treatment with anti-leishmanial drugs.

Authors:  Mariana Gatto; Mariana Miziara de Abreu; Karen Ingrid Tasca; Marjorie de Assis Golim; Laura Denise Mendes da Silva; José Cláudio Simão; Carlos Magno Castelo Branco Fortaleza; Ângela Maria Victoriano de Campos Soares; Sueli Aparecida Calvi
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

9.  l-Arginine Uptake by Cationic Amino Acid Transporter Promotes Intra-Macrophage Survival of Leishmania donovani by Enhancing Arginase-Mediated Polyamine Synthesis.

Authors:  Abhishek Mandal; Sushmita Das; Ajay Kumar; Saptarshi Roy; Sudha Verma; Ayan Kumar Ghosh; Ruby Singh; Kumar Abhishek; Savita Saini; Abul Hasan Sardar; Bidyut Purkait; Ashish Kumar; Chitra Mandal; Pradeep Das
Journal:  Front Immunol       Date:  2017-07-26       Impact factor: 7.561

10.  Deprivation of L-Arginine Induces Oxidative Stress Mediated Apoptosis in Leishmania donovani Promastigotes: Contribution of the Polyamine Pathway.

Authors:  Abhishek Mandal; Sushmita Das; Saptarshi Roy; Ayan Kumar Ghosh; Abul Hasan Sardar; Sudha Verma; Savita Saini; Ruby Singh; Kumar Abhishek; Ajay Kumar; Chitra Mandal; Pradeep Das
Journal:  PLoS Negl Trop Dis       Date:  2016-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.